Skip to main content
RB logo RB logo
5.000.00 GBX +3.00 (0.2%)
  • About us
    About us

    We create simple, innovative products that make it easy for individuals, families and communities to live healthier and happier.

    About us
    • Who we are
    • Our purpose and compass
    • Our Leadership
    • Contact us
    • Coronavirus information
  • Brands
    Brands

    Available in nearly 200 countries, our brands are loved and trusted by people all over the world.

    Brands
    • Clearasil
    • Enfa
    • Finish
    • Lysol
    • Veet
    • Dettol
    • Air Wick
    • Durex
    • Calgon
    • Mortein
    • Cillit Bang
    • Nurofen
    • Nutramigen
    • Scholl
    • Strepsils
    • Woolite
    • Vanish
    • Harpic
  • Careers
    Careers

    We are the community behind some of the world’s most beloved brands. Together we shape healthier lives and happier homes for people across the globe.

    Careers
    • Our people
      • Clare
      • Rakshet
      • Sunny
      • Yawer
      • Caroline
  • Investors
    Investors

    RB is a global consumer goods company listed within the top 25 of the London Stock Exchange.

    Investors
    • Investor information
    • The Board
    • Investor tools
      • Regulatory news
      • Share price calculator
      • Historical share price
      • Detailed share price
    • Corporate Governance
      • RB Subsidiaries
    • Your shareholding
      • AGM
      • ADR Information
      • Dividend information
      • Debt investors
      • Dividend payments
    • Annual report 2019
  • Sustainability
    Sustainability

    We exist to protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. This means operating in a responsible and sustainable way while innovating products that improve lives while reducing environmental impacts.

    Sustainability
    • The RB Fight for Access Fund
    • Our approach
    • Key issues and stakeholders
    • Sustainable business
      • Sustainable innovation
      • Product safety and stewardship
      • Plastics and packaging
      • Infant and child nutrition
      • Business ethics
      • Humidifier sanitizer
      • The Economic Impact of RB in the US
    • Environment
      • Climate change and energy
      • Water
      • Responsible supply chain and sourcing
      • Waste from operations
    • People and communities
      • People and culture
      • Gender pay
      • Health and safety
      • Social impact investment
      • Human rights
    • Recognition and partnerships
    • Performance data
    • Policies and reports
  • Newsroom
    Newsroom

    See the latest news and investor news from RB. Find investor information and see what the media are saying about RB.

    Newsroom
    • Latest News
  • Innovation
    Innovation
    Innovation
    • Hygiene Innovation
      • Our key verticals
    • Health Innovation
      • Our innovation focus
      • The Future Consumer
    • Scale your business
    • Innovation Labs
    • Partner with us
    • Submit an idea
    • The future of self-care
Our global sites

Explore our global sites with local content specific to each country.

  • Global

  • Japan

  • Brazil

  • Germany

  • Russia

  • USA

  • Korea

rb logo
6,164.00 GBX+76.00 +1.25%
Your search for ' ' returned the following results:
You are viewing of results
Home Investors The Board

Olivier Bohuon

  • Investors
  • Investor information
  • The Board
  • Investor tools
    • Regulatory news
    • Share price calculator
    • Historical share price
    • Detailed share price
  • Corporate Governance
    • RB Subsidiaries
  • Your shareholding
    • AGM
    • ADR Information
    • Dividend information
    • Debt investors
    • Dividend payments
  • Annual report 2019
Back

Olivier Bohuon

Non-Executive Director

Appointment

Appointed as a Non-Executive Director in January 2021.

Career

Olivier was CEO of FTSE 100 medical devices company Smith & Nephew from 2011 to 2018. Prior to that role he served as CEO of healthcare, cosmetology and pharmaceutical company Laboratoires Pierre Fabre from 2010 to 2011 and from 2003 – 2010 he worked at Abbott Laboratories, rising to Corporate Executive Vice President and President of the pharmaceutical products division. Earlier in his career, Olivier worked at GlaxoSmithKline plc in positions of increasing seniority. He also served on the Board of Smiths Group plc from July 2018 to November 2020. Olivier became a Knight of the Legion of Honour in 2007.

Olivier has a doctorate in Pharmacy from University of Paris-Sud and an MBA from HEC in Paris.

Skills and competencies

Olivier is a successful leader, with many years of experience as CEO of a large global company. Olivier has deep experience in healthcare products and markets and will bring great insight to the Board.

Current external appointments

Chairman of Leo Pharma

External Director of Takeda Pharmaceutical Company Limited

Member of the Supervisory Board of Virbac SA

Member of the National Pharmacy Academy

Member of the Academy of Technologies

Address

Registered office at 103 - 105 Bath Road, Slough, Berkshire, SL1 3UH

Registered in England & Wales, No 6270876

rb.com

  • About us
  • Brands
  • Careers
  • Investors
  • Sustainability
  • Newsroom
  • Innovation

Investors

  • Investor information
  • The Board
  • Investor tools
  • Corporate Governance
  • Your shareholding
  • Annual report 2019

More

  • Terms and Conditions
  • Privacy Policy
  • Cookie Policy
  • Modern Slavery Act Statement

© Copyright Reckitt Benckiser Group plc. All rights reserved